Effect of cyclic 3',5'-monophosphate on edema and granuloma induced by carrageenin.
D000305:Adrenal Cortex Hormones / Q000378:metabolism; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001786:Blood Glucose; D001920:Bradykinin / Q000494:pharmacology; D002056:Burns / Q000188:drug therapy; D002199:Capillary Permeability / Q000187:drug effects; D002351:Carrageenan; D003345:Corticosterone / Q000032:analysis; D000242:Cyclic AMP / Q000627:therapeutic use*; D004347:Drug Interactions; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy*; D005470:Fluorometry; D006099:Granuloma / Q000139:chemically induced / Q000188:drug therapy*; D006632:Histamine / Q000494:pharmacology; D006854:Hydrocortisone / Q000032:analysis; D008112:Liver Glycogen / Q000032:analysis; D008297:Male; D051381:Rats; D013806:Theophylline / Q000627:therapeutic use; D013997:Time Factors
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D001786:Blood Glucose; D008112:Liver Glycogen; D006632:Histamine; D002351:Carrageenan; D013806:Theophylline; D000242:Cyclic AMP; D001920:Bradykinin; D003345:Corticosterone; D006854:Hydrocortisone